Trump's Bold Move to Slash Drug Prices

U.S. President Donald Trump announced a significant plan to cut prescription drug prices by 59% but provided no specifics. His proposal, related to the 'most favored nation' pricing, impacted pharmaceutical stocks globally, as investors awaited further details ahead of a White House event on healthcare.

U.S. President Donald Trump has made a striking announcement regarding prescription drug prices, committing to a 59% reduction. However, specifics of the plan remain undisclosed, leaving many in anticipation.

The declaration was shared on social media, where Trump capitalized his intent to enact significant cuts. This announcement comes as pharmaceutical stocks experienced a downturn on Monday morning.

On Sunday, Trump mentioned his intention to sign an executive order targeting 'most favored nation' pricing. This international reference pricing strategy is expected to reshape pharmaceutical pricing, affecting market dynamics and drawing widespread attention ahead of the White House's impending healthcare event.